Search

Tara L. Martinez

Examiner (ID: 12501)

Most Active Art Unit
1654
Art Unit(s)
1654, 1675
Total Applications
718
Issued Applications
367
Pending Applications
92
Abandoned Applications
264

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16539399 [patent_doc_number] => 20200405812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => METHODS OF DELIVERING HEPARIN BINDING EPIDERMAL GROWTH FACTOR USING STEM CELL GENERATED EXOSOMES [patent_app_type] => utility [patent_app_number] => 16/517201 [patent_app_country] => US [patent_app_date] => 2019-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18605 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16517201 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/517201
METHODS OF DELIVERING HEPARIN BINDING EPIDERMAL GROWTH FACTOR USING STEM CELL GENERATED EXOSOMES Jul 18, 2019 Abandoned
Array ( [id] => 15035693 [patent_doc_number] => 20190328851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-31 [patent_title] => Stabilised Solid Compositions of Factor VII Polypeptides [patent_app_type] => utility [patent_app_number] => 16/507115 [patent_app_country] => US [patent_app_date] => 2019-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13567 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16507115 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/507115
Stabilised Solid Compositions of Factor VII Polypeptides Jul 9, 2019 Abandoned
Array ( [id] => 15086915 [patent_doc_number] => 20190338268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-07 [patent_title] => Complement Factor B Analogs and Their Uses [patent_app_type] => utility [patent_app_number] => 16/502623 [patent_app_country] => US [patent_app_date] => 2019-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32359 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16502623 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/502623
Complement factor B analogs and their uses Jul 2, 2019 Issued
Array ( [id] => 15993407 [patent_doc_number] => 20200172574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-04 [patent_title] => INHIBITION OF CARDIAC FIBROSIS IN MYOCARDIAL INFARCTION [patent_app_type] => utility [patent_app_number] => 16/460645 [patent_app_country] => US [patent_app_date] => 2019-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43042 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16460645 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/460645
INHIBITION OF CARDIAC FIBROSIS IN MYOCARDIAL INFARCTION Jul 1, 2019 Abandoned
Array ( [id] => 15493313 [patent_doc_number] => 20200046845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-13 [patent_title] => CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY [patent_app_type] => utility [patent_app_number] => 16/450239 [patent_app_country] => US [patent_app_date] => 2019-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 113055 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16450239 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/450239
CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY Jun 23, 2019 Abandoned
Array ( [id] => 15086381 [patent_doc_number] => 20190338001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-07 [patent_title] => Composition Containing SMAD Protein for Treatment of Autoimmune Diseases, a Fusion Protein Comprising SMAD Protein, an Expression Vector and a Method for Preparing the Same [patent_app_type] => utility [patent_app_number] => 16/443093 [patent_app_country] => US [patent_app_date] => 2019-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12153 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16443093 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/443093
Composition Containing SMAD Protein for Treatment of Autoimmune Diseases, a Fusion Protein Comprising SMAD Protein, an Expression Vector and a Method for Preparing the Same Jun 16, 2019 Abandoned
Array ( [id] => 14993725 [patent_doc_number] => 20190315820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => A Composition Containing SMAD Protein for Treatment of Autoimmune Diseases, a Fusion Protein Comprising SMAD Protein, an Expression Vector and a Method for Preparing the Same [patent_app_type] => utility [patent_app_number] => 16/443089 [patent_app_country] => US [patent_app_date] => 2019-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12166 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16443089 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/443089
A Composition Containing SMAD Protein for Treatment of Autoimmune Diseases, a Fusion Protein Comprising SMAD Protein, an Expression Vector and a Method for Preparing the Same Jun 16, 2019 Abandoned
Array ( [id] => 14963089 [patent_doc_number] => 20190309022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-10 [patent_title] => NOVEL MODULATORS OF MELANOCORTIN RECEPTORS [patent_app_type] => utility [patent_app_number] => 16/431361 [patent_app_country] => US [patent_app_date] => 2019-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2740 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16431361 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/431361
Modulators of melanocortin receptors Jun 3, 2019 Issued
Array ( [id] => 16883795 [patent_doc_number] => 20210169990 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2021-06-10 [patent_title] => Compostions for Treating Dry Eye Disease [patent_app_type] => utility [patent_app_number] => 16/420361 [patent_app_country] => US [patent_app_date] => 2019-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12750 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16420361 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/420361
Compostions for Treating Dry Eye Disease May 22, 2019 Abandoned
Array ( [id] => 16883795 [patent_doc_number] => 20210169990 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2021-06-10 [patent_title] => Compostions for Treating Dry Eye Disease [patent_app_type] => utility [patent_app_number] => 16/420361 [patent_app_country] => US [patent_app_date] => 2019-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12750 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16420361 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/420361
Compostions for Treating Dry Eye Disease May 22, 2019 Abandoned
Array ( [id] => 14963087 [patent_doc_number] => 20190309021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-10 [patent_title] => Composition Comprising a Peptide and an Inhibitor of Viral Neuraminidase [patent_app_type] => utility [patent_app_number] => 16/418265 [patent_app_country] => US [patent_app_date] => 2019-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5729 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16418265 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/418265
Composition Comprising a Peptide and an Inhibitor of Viral Neuraminidase May 20, 2019 Abandoned
Array ( [id] => 16680760 [patent_doc_number] => 10940216 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-09 [patent_title] => Cyclic peptides with enhanced nerve-binding selectively, nanoparticles bound with said cyclic peptides, and use of same for real-time in vivo nerve tissue imaging [patent_app_type] => utility [patent_app_number] => 16/414874 [patent_app_country] => US [patent_app_date] => 2019-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 45 [patent_no_of_words] => 9031 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16414874 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/414874
Cyclic peptides with enhanced nerve-binding selectively, nanoparticles bound with said cyclic peptides, and use of same for real-time in vivo nerve tissue imaging May 16, 2019 Issued
Array ( [id] => 17655490 [patent_doc_number] => 20220175955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => PEPTIDE DISPLAY TO ANTIGEN PRESENTING CELLS USING LIPID VEHICLE [patent_app_type] => utility [patent_app_number] => 17/055197 [patent_app_country] => US [patent_app_date] => 2019-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28067 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17055197 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/055197
PEPTIDE DISPLAY TO ANTIGEN PRESENTING CELLS USING LIPID VEHICLE May 13, 2019 Abandoned
Array ( [id] => 17029965 [patent_doc_number] => 11091771 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-17 [patent_title] => PHI-4 polypeptides and methods for their use [patent_app_type] => utility [patent_app_number] => 16/406216 [patent_app_country] => US [patent_app_date] => 2019-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 87826 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 421 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16406216 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/406216
PHI-4 polypeptides and methods for their use May 7, 2019 Issued
Array ( [id] => 14864855 [patent_doc_number] => 20190282669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-19 [patent_title] => PROPHYLACTIC AND NUTRACEUTICAL THERAPY [patent_app_type] => utility [patent_app_number] => 16/389451 [patent_app_country] => US [patent_app_date] => 2019-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12050 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16389451 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/389451
Prophylactic and nutraceutical therapy Apr 18, 2019 Issued
Array ( [id] => 14896935 [patent_doc_number] => 20190292233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-26 [patent_title] => ANTIMICROBIAL PEPTIDES [patent_app_type] => utility [patent_app_number] => 16/383823 [patent_app_country] => US [patent_app_date] => 2019-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16859 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16383823 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/383823
Antimicrobial peptides Apr 14, 2019 Issued
Array ( [id] => 14896937 [patent_doc_number] => 20190292234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-26 [patent_title] => ANTIMICROBIAL PEPTIDES [patent_app_type] => utility [patent_app_number] => 16/383865 [patent_app_country] => US [patent_app_date] => 2019-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16854 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16383865 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/383865
ANTIMICROBIAL PEPTIDES Apr 14, 2019 Abandoned
Array ( [id] => 18716536 [patent_doc_number] => 11793858 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-24 [patent_title] => Bactericidal peptides and uses thereof [patent_app_type] => utility [patent_app_number] => 17/045614 [patent_app_country] => US [patent_app_date] => 2019-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 13078 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17045614 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/045614
Bactericidal peptides and uses thereof Apr 14, 2019 Issued
Array ( [id] => 17720418 [patent_doc_number] => 20220213138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-07 [patent_title] => CYCLIC COMPOUNDS AND METHODS OF MAKING AND USING [patent_app_type] => utility [patent_app_number] => 17/600922 [patent_app_country] => US [patent_app_date] => 2019-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31405 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 443 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17600922 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/600922
CYCLIC COMPOUNDS AND METHODS OF MAKING AND USING Apr 3, 2019 Pending
Array ( [id] => 14530051 [patent_doc_number] => 20190200646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-04 [patent_title] => Beverage with Collagen and Additional Additives [patent_app_type] => utility [patent_app_number] => 16/353179 [patent_app_country] => US [patent_app_date] => 2019-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7713 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16353179 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/353179
Beverage with Collagen and Additional Additives Mar 13, 2019 Abandoned
Menu